Target intelligence / Profile preview

Haliscomenobacter hydrossis D-amino acid transaminase (Halhy)

Target
Halhy
Molecular classification
Enzyme, Pyridoxal-5'-phosphate-dependent transaminase, Fold type IV transaminase
01

Overview

Haliscomenobacter hydrossis D-amino acid transaminase (Halhy) is a pyridoxal-5'-phosphate (PLP)-dependent enzyme belonging to the fold type IV transaminase superfamily. It catalyzes the reversible stereoselective transfer of an amino group from a D-amino acid to an α-keto acid, producing a new D-amino acid and its corresponding keto acid. In bacteria, D-amino acid transaminases (DAATs) are essential for the synthesis of D-glutamate, a critical component of the peptidoglycan layer in the cell wall. Halhy is particularly distinguished by its high catalytic efficiency and a unique active site architecture featuring three arginine residues that facilitate substrate binding. While DAATs are considered potential targets for the development of novel antibacterial agents due to their absence in humans, Halhy is currently primarily utilized as a robust biocatalyst in the pharmaceutical industry for the asymmetric synthesis of enantiomerically pure D-amino acids. These D-amino acids serve as vital building blocks for various bioactive compounds and drugs. The enzyme demonstrates strict stereoselectivity, ensuring that no L-amino acid products are formed during the reaction.

Other names
D-amino acid transaminaseD-amino acid aminotransferaseDAATDATATA_Halhy
02

Mechanism of action

Inhibition of D-amino acid transaminase activity, leading to the depletion of D-glutamate and D-alanine required for bacterial cell wall peptidoglycan synthesis.

03

Biological functions

Amino acid metabolismD-amino acid synthesisCell wall peptidoglycan biosynthesis
04

Disease associations

Infection
05

Safety considerations

Potential for off-target effects if inhibitors cross-react with other human pyridoxal-5'-phosphate-dependent enzymesTherapeutic challenge of achieving sufficient intracellular concentration in gram-negative bacteria
06

Interacting drugs

3-aminooxypropionic acid

Beyond the preview

Go deeper on Haliscomenobacter hydrossis D-amino acid transaminase (Halhy).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Haliscomenobacter hydrossis D-amino acid transaminase (Halhy).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call